We Are Reshaping
Cancer
Detection
What is ACTIVH
The ACTIVH test requires a blood draw, allowing integration into existing patient touchpoints such as an annual health check or routine blood work. ACTIVH detects activated circulating hepsin within the blood, which has been linked in over 500 clinical and preclinical studies to metastatic cancer.
Recommended Use
ActivH is an accurate method of triaging and establishing patient hepsin-level baselines.
Ordering & Results
Receive results quickly to determine further necessary screening.
Patient Cost
ACTIVH only costs $99, making it a cost-effective option for determining further screening.
Results & Next Steps
Take away the guessing game with ACTIVH early cancer detection.
When to Use ACTIVH
ActivH is effectively used to assist in triaging patients with unclear family histories and determine if further screening is necessary.
How to Use ACTIVH
From ordering tests to receiving results, Navaux expedites the metastatic disease screening process.
Order Tests
Contact Navaux to receive your ACTIVH tests
Collect Sample
Administer blood test to determine patient baseline
Receive Results
Determine further screening based on activated hepsin levels
Activated Hepsin Levels
This example test result shows hepsin levels within a suspicious range.
Next Steps
supporting copy
Activated Circulating Hepsin Detected
When activated hepsin is detected, further screening can be administered to determine the specific metastatic disease.
Activated Circulating Hepsin Not Detected
When activated hepsin is not detected, continue normal patient touch points.
Ordering Process
Elevate your triaging process today
